30 Day Psychedelic Pharmacology Podcast - Day 20 Therapy Integration episode artwork

EPISODE · Jan 30, 2025 · 16 MIN

30 Day Psychedelic Pharmacology Podcast - Day 20 Therapy Integration

from Cannabinoid and Psychedelic Pharmacology and Drug Development

This podcast episode explores how psychedelics like psilocybin and MDMA enhance psychotherapy through their effects on brain chemistry and neural pathways. The discussion covers key mechanisms including the 5HT2A receptor, oxytocin release, and connections between the amygdala and prefrontal cortex. The speakers examine how these substances can promote synaptic plasticity and fear extinction, particularly beneficial for conditions like PTSD. They also address important challenges in the field, including therapist training requirements and FDA regulatory concerns. The conversation concludes by considering the broader implications of psychedelic-assisted therapy for mental healthcare and human potential.

Episode metadata supplied by the publisher feed · Published Jan 30, 2025

Embed this episode

NOW PLAYING

30 Day Psychedelic Pharmacology Podcast - Day 20 Therapy Integration

0:00 16:59

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Cannabinoid and Psychedelic Pharmacology and Drug Development?

This episode is 16 minutes long.

When was this Cannabinoid and Psychedelic Pharmacology and Drug Development episode published?

This episode was published on January 30, 2025.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this Cannabinoid and Psychedelic Pharmacology and Drug Development episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!